Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Central Imaging Review Analysis with mint Lesion

Central Imaging Review Analysis with mint Lesion - read-ready in minutes, not weeks

Watch in the video above a demonstration of our central imaging review software featuring a pre-configured, master trial workflow database designed to support your study requirements with read-ready functionality quickly available.

  • Multiple read paradigms: Support for single reads, double reads with adjudication, and eligibility workflows
  • Multi-criteria reads: Apply multiple evaluation frameworks to the same image
  • Flexible templates: Use standard response criteria read templates or custom eCRFs you design
  • Built-in analytics: Volumetrics, SUVs, tumor growth rates, and radiomics capabilities
  • Automated notifications: Alerts configured to align with your review flow
  • Export functionality: One-click exports for images, data (CDISC, radiomics, observations), and structured results

 

Related Resources

Related Resources

AI lung nodules detection in contextflow and Lung-RADS in mint Lesion

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule…

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…

Image shows graphic related to study's research on iRECIST and RECIST

University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…